TY - JOUR

T1 - Artificial Intelligence in Pharmacoepidemiology

T2 - A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial Intelligence

AU - Sessa, Maurizio

AU - Khan, Abdul Rauf

AU - Liang, David

AU - Andersen, Morten

AU - Kulahci, Murat

PY - 2020

Y1 - 2020

N2 - Aim: To perform a systematic review on the application of artificial intelligence (AI) based knowledge discovery techniques in pharmacoepidemiology. Study Eligibility Criteria: Clinical trials, meta-analyses, narrative/systematic review, and observational studies using (or mentioning articles using) artificial intelligence techniques were eligible. Articles without a full text available in the English language were excluded. Data Sources: Articles recorded from 1950/01/01 to 2019/05/06 in Ovid MEDLINE were screened. Participants: Studies including humans (real or simulated) exposed to a drug. Results: In total, 72 original articles and 5 reviews were identified via Ovid MEDLINE. Twenty different knowledge discovery methods were identified, mainly from the area of machine learning (66/72; 91.7%). Classification/regression (44/72; 61.1%), classification/regression + model optimization (13/72; 18.0%), and classification/regression + features selection (12/72; 16.7%) were the three most frequent tasks in reviewed literature that machine learning methods has been applied to solve. The top three used techniques were artificial neural networks, random forest, and support vector machines models. Conclusions: The use of knowledge discovery techniques of artificial intelligence techniques has increased exponentially over the years covering numerous sub-topics of pharmacoepidemiology. Systematic Review Registration: Systematic review registration number in PROSPERO: CRD42019136552.

AB - Aim: To perform a systematic review on the application of artificial intelligence (AI) based knowledge discovery techniques in pharmacoepidemiology. Study Eligibility Criteria: Clinical trials, meta-analyses, narrative/systematic review, and observational studies using (or mentioning articles using) artificial intelligence techniques were eligible. Articles without a full text available in the English language were excluded. Data Sources: Articles recorded from 1950/01/01 to 2019/05/06 in Ovid MEDLINE were screened. Participants: Studies including humans (real or simulated) exposed to a drug. Results: In total, 72 original articles and 5 reviews were identified via Ovid MEDLINE. Twenty different knowledge discovery methods were identified, mainly from the area of machine learning (66/72; 91.7%). Classification/regression (44/72; 61.1%), classification/regression + model optimization (13/72; 18.0%), and classification/regression + features selection (12/72; 16.7%) were the three most frequent tasks in reviewed literature that machine learning methods has been applied to solve. The top three used techniques were artificial neural networks, random forest, and support vector machines models. Conclusions: The use of knowledge discovery techniques of artificial intelligence techniques has increased exponentially over the years covering numerous sub-topics of pharmacoepidemiology. Systematic Review Registration: Systematic review registration number in PROSPERO: CRD42019136552.

KW - artificial intelligence

KW - deep learning

KW - machine learning

KW - pharmacoepidemiology

KW - systematic review

U2 - 10.3389/fphar.2020.01028

DO - 10.3389/fphar.2020.01028

M3 - Review

C2 - 32765261

AN - SCOPUS:85088825774

VL - 11

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 1028

ER -